ImaginAb, an immuno-oncology imaging company, has raised an additional $8 million in new equity funding led by Adage Capital. The company's shareholders also include the Parker Institute for Cancer Immunotherapy, NVF, Cycad Group, Nextech Invest, and Jim Pallotta of the Raptor Group.
Martyn Coombs, CEO of ImaginAb commented, "We are thrilled to raise this new round of funding which provides the necessary fuel to accelerate development of our CD8 ImmunoPET program. We are rebooting the Co
RelSci News & Alerts gets you: